Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Mats Rahmström comments on Atlas Copco’s Q2 2017

Stockholm, Sweden, July 17, 2017: Atlas Copco, a leading provider of sustainable productivity solutions, today reported strong demand and record revenues and operating profit. In the near term, the overall demand for the Group is expected to remain at current high level.Orders received in the second quarter grew to MSEK 30 797 (25 207), an organic increase of 11%. Revenues were MSEK 29 030 (24 565), and the adjusted operating profit margin was 21.5% (19.6). Growth was especially strong in Asia where all the business areas grew significantly. Among segments, the semiconductor industry

Atlas Copco second-quarter report 2017

Strong customer demand and record profit The figures presented in this report refer to continuing operations unless otherwise stated.• Orders increased 22% to MSEK 30 797 (25 207), organic increase of 11%• Revenues were MSEK 29 030 (24 565), organic growth of 7%• Operating profit increased 26% to MSEK 5 988 (4 769)     • Adjusted operating profit was MSEK 6 244 (4 816), corresponding to a margin of 21.5% (19.6)• Profit before tax amounted to MSEK 5 620 (4 428)• Profit for the period was MSEK 4 084 (3 198)• Basic earnings per share were SEK 3.36 (2.63)• Operating cash flow

Fiskars to publish its Half Year Financial Report for January–June 2017 on August 1, 2017

Fiskars Corporation     Press releaseJuly 17, 2017 at 12:00 (EEST) Fiskars to publish its Half Year Financial Report for January–June 2017 on August 1, 2017 Fiskars Corporation will publish its Half Year Financial Report for January–June 2017 on August 1, 2017 at approximately 8:30 a.m. (EEST). The Half Year Report will be available on the company’s website www.fiskarsgroup.com after publication.Analyst and media conferenceA presentation for analysts and media on the first quarter results will be held on August 1, 2017 at 10:00 a.m. at the company’s headquarters, Fiskars

Interim Report Second Quarter 2017

Second quarter 2017 Continuing operations   · Order intake 24,533 million SEK · Revenues 23,553 million SEK · Operating profit 3,271  million SEK · Operating margin 13.9% · Adjusted operating profit 3,721 million SEK · Adjusted operating margin 15.8% · Profit after financial items 3,045 million SEK · Earnings per share 1.75 SEK · Cash flow from operations 2,493 million SEK Discontinued operations · Order intake 407 million SEK · Revenues 893 million SEK · Operating profit 13 million SEK Group Total · Order intake 24,940 million SEK ·

Axel Johnson International acquires IOW Group

Axel Johnson International has signed an agreement to acquire a majority of the shareholdings in the IOW Group of companies, with presence in Poland, Bulgaria, Czech Republic and the Baltic countries. The IOW Group, with revenues of EUR 27 m and approximately 130 employees, is a leading distributor and service provider of mobile drivetrain systems, hydraulics, cooling systems and filter technologies in Central and Eastern Europe.IOW Group was established in 1993 and has a long-term relationship with its customers and suppliers. The customers are mainly Original Equipment Manufacturers (OEMs)

Bormioli Luigi and Triton partnered to acquire the Bormioli Rocco tableware and pharma businesses respectively

Milan / Fidenza (Italy), 17 July 2017 – Bormioli Luigi S.p.A. has partnered with Funds advised by Triton (“Triton”) to purchase the Pharma and Tableware business divisions of the Bormioli Rocco group. Both business divisions will be owned and run independently of each other, as Bormioli Luigi will acquire the Tableware division and Triton will acquire the Pharma division. Bormioli Rocco is a leading Italian tableware and pharma primary packaging manufacturer currently owned by Vision Capital. The transactions are subject to regulatory approval in the relevant jurisdictions. Any necessary

AAK’s Interim report for the second quarter 2017 – all-time high operating profit for a second quarter

· Operating profit reached SEK 409 million (368), an improvement of 11 percent. The currency translation impact was SEK 6 million, entirely related to Chocolate & Confectionery Fats.- Ramp-up costs for the greenfield projects in Brazil and China have, according to plan, been absorbed in the reported profit. · Total volumes continued to grow nicely and were up 11 percent (6). Organic volume growth was 5 percent (1). The demand for speciality and semi-speciality products continued to be strong and generated organic volume growth of 5 percent (5). · Food Ingredients improved by 14

FreiLacke implements IFS Applications 9 to support international growth

System coatings provider FreiLacke to replace numerous legacy systems with comprehensive ERP solution from IFS with a key benefits being improved visibility and access to manage the company’s value chainIFS , the global enterprise applications company, announces that FreiLacke , a leading provider of system coatings with headquarter in Doeggingen, Germany, has decided to implement IFS Applications™ 9 . With the new solution, the company modernizes its

SimCorp A/S – Share buyback program

On 27 February 2017 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 17.5m (approx. DKK 130.4m) in the period from 27 February 2017 to 23 August 2017. The following transactions have been executed under the program:     Date                 Number of shares Average Amount (DKK)

Strong momentum in RayStation proton therapy sales

Eight additional proton therapy centers worldwide have chosen RayStation as their treatment planning system. Six of the orders were received in June 2017: the Children’s Cancer Hospital Foundation (Cairo, Egypt), Hospital Quirónsalud (Madrid, Spain); Mayo Clinic Hospital (Phoenix, US); ZON-PTC (Maastricht, Netherlands); MedStar Georgetown University Hospital (Washington DC, US) and the Johns Hopkins Medicine proton center at Sibley Memorial Hospital (Washington DC, US). RayStation was also recently selected by Tata Memorial Center in Mumbai, one of India’s first proton therapy facilities, and

Bravida takes on large coordination project when Region Kronoberg builds new psychiatry facilities

Region Kronoberg will build new facilities for adult psychiatry in the Sankt Sigfrid area in Växjö. Bravida has been assigned by Dynacon Construction AB to coordinate and execute all installations to an order value of approximately SEK 110 million.The new premises of 16,000 square meters will contain elderly, psychosis, addictive and general psychiatry, as well as an psychiatric emergency room. That means high demands on the technical installations. Håkan Stjernqvist, CEO of Dynacon Construction AB: – This kind of medical activity put high demands on the technical solutions, where the

Chelsea Football Club appoints Ericsson as Connected Venue Partner

· Ericsson unveiled as connectivity partner for Stamford Bridge – Chelsea Football Club’s home stadium in Fulham, London · Small Cell as a Service business model sees Ericsson designing, building and operating a carrier-grade Wi-Fi network on the customer’s behalf · Visitors to the stadium will enjoy a richer experience that enables them to interact digitally with each other, the club, friends and familyEricsson (NASDAQ: ERIC) has been unveiled as the connectivity partner for Stamford Bridge – Chelsea Football Club’s home stadium in Fulham, London. Free Wi-Fi coverage will be provided

YIT to start a new apartment building project in the Moscow region, Russia

YIT Corporation Investor News July 17, 2017 at 10:00 a.m.YIT starts the construction of a new apartment building project in Zhukovsky, Moscow Region, Russia. The project will comprise approximately 220 apartments as well as business premises. The total value of the project is approximately EUR 15 million and it will be completed by the end of 2018. The start-up was recorded in the second quarter. The project is the latest phase of an area development project called Microdistrict 5A. Over ten years, the Microdistrict 5A project has already completed apartments with over 180,000 square

Photocure ASA : UPDATE ON MEDICARE REIMBURSEMENT FOR BLUE LIGHT CYSTOSCOPY WITH CYSVIEW®

Oslo, Norway, July 17, 2017: Photocure ASA (OSE: PHO), announced today that the United States Centers for Medicare & Medicaid Services (CMS) has released the Proposed Rule outlining its 2018 plan to reimburse hospital outpatient departments using Blue Light Cystoscopy (BLC[TM]) with Cysview[®]. To ensure appropriate reimbursement for BLCTM with Cysview, CMS has proposed to create a new set of codes specific to Blue Light Cystoscopy allowing for improved reimbursement for those procedures. The CMS draft rule for Medicare patients can be accessed at: http://bit.ly/CMS-DRAFT-Rule "We are

Outotec to deliver shutdown services to a copper smelter in South America

OUTOTEC OYJ   PRESS RELEASE, JULY 17, 2017 AT 10.00 AM Outotec to deliver shutdown services to a copper smelter in South America Outotec has been awarded a contract for shutdown services to a copper smelter in South America. The approximately EUR 12 million order has been booked in Outotec's 2017 second quarter order intake. Outotec's scope of work includes the demolition and reconstruction of a smelting furnace originally designed and delivered by Outotec. The service will be delivered during the third quarter of 2017. "This order demonstrates our commitment to delivering life-

Presentation of Probi’s Q2 report 2017

Probi’s report for the second quarter 2017 will be published on Wednesday, 19 July at 8.00 a.m. CET In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Peter Nählstedt and CFO Jörn Andreas will present and comment on the report. The presentation and presentation material can be obtained via www.probi.se or http://www.financialhearings.com/event/10013  The presentation can also be followed via a telephone conference on the following telephone number:Sweden: +46 8 56 64 26 91UK: +44 20 30

Leading expert on pancreatic cancer, Professor Stephen Pereira at University College London, joins Immunovia’s Scientific Advisory Board

LUND, Sweden ― Immunovia announced today that Professor Stephen Pereira, one of the globally leading experts in the diagnosis of early symptoms of pancreatic cancer and a multidisciplinary diagnostic center champion has been appointed to the company’s Scientific Advisory Board. Currently, Pereira is Professor of Hepatology & Gastroenterology at UCL, University College London, and an honorary consultant in pancreaticobiliary medicine at UCL Hospitals and The Royal Free Hospital.Professor Pereira has been involved during the last two years in the set-up of multidisciplinary diagnostic centres

NOTE’s Interim Report January–June 2017

Financial performance April–June• Sales increased by 9% to SEK 308.4 (282.4) million. Excluding divestments, sales increased by 12%.• Operating profit rose to SEK 20.3 (15.4) million.• Operating margin expanded by 1.1 percentage points to 6.6% (5.5%).• Profit after financial items increased to SEK 19.3 (13.6) million.• Profit after tax rose to SEK 11.6 (11.0) million, corresponding to SEK 0.40 (0.38) per share, of which SEK -0.14 (-) consisted of write-down of foreign deferred taxes.• Cash flow after investments amounted to SEK 1.3 (4.1) million, or SEK 0.05 (0.14) per share.

ExpreS2ion enters multi-product agreement with US-based Integrated BioTherapeutics for expansion of their commercial reagents portfolio

Hørsholm, Denmark, July 17, 2017 – Today, ExpreS2ion Biotech Holding AB announces that the fully owned subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) has entered a Master Services Agreement and a Research & Commercial License Agreement with the US based Integrated BioTherapeutics, Inc. (“IBT”). The agreements enable standardised activation of a range of services and products from ExpreS2ion. This primarily targets the development and manufacturing of proteins based on the ExpreS2 platform, as well as granting IBT commercial rights to promote, sell and distribute such protein

Handelsbanken’s interim report for January-June 2017 will be presented on July 18

Handelsbanken will present its results for January­‑June 2017 in Stockholm on July 18, 2017, at 9:00 a.m. CET, at a meeting with the media and analysts. The interim report for January‑June 2017 will be published at 7:00 a.m. CET, on July 18, 2017. A telephone conference will be held at 10:30 a.m. CET (4:30 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203–364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions1.     Dial +xx xxx xx 10

Mycronic receives order for a Prexision-MMS system and an upgrade

Täby, 17 July, 2017 - Mycronic AB (publ), has received order for a Prexision-MMS for quality assurance of advanced photomasks from a customer in Asia. The system is scheduled to be delivered in the end of 2018. At the same time, the customer has ordered an upgrade of a previously delivered mask writer Prexision-8. This system will be upgraded to a full scale Generation 10 (G10) photomask production unit.The total order value, including the Prexision-MMS and the Prexision system upgrade, is in the span USD 18-22 million.  Mycronic offers mask writers for the manufacturing of photomasks

Sales development in June 2017

The H&M group’s sales including VAT increased by 7 percent in local currencies in June 2017 compared to the same month the previous year. Converted into SEK sales increased by 10 percent. The total number of stores in the group amounted to 4,517 on 30 June 2017 compared to 4,095 stores on30 June 2016. The H&M group has decided to arrange Capital Markets Days during which more in-depth information about the business will be given and has also decided – in consultation with its large institutional shareholders – to publish the group’s sales development per quarter instead of per month.

Interim report January - June 2017

In the second quarter, Byggmax increased net sales by 2.1% and profit (EBITDA) by 8.5%  During the second quarter 2017, Byggmax Group increased sales and strengthened margins. The Group’s selling increased 2.1% following strong comparable figures for the same period last year. EBITDA margin improved significantly to 11.8%, an increase by 0.7%-points (11.1% same period last year). In June, Byggmax Group presented a new strategy, and the implementation has started according to plan.April 1 - June 30 · Net sales amounted to SEK 1,775.8 M ( 1,738.7 ), up 2.1 percent. · Net sales for

There are no items matching the current filter
There are no more items matching the current filter
Back to top